SCHEMBL22078596

SCHEMBL22078596

C=C(C)C(=O)Oc1ccc(-c2ccc3ccc(-c4ccc(OC(=O)C(=C)C)cc4)cc3c2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 1/20 0.51
KMT2A Q03164 2/20 0.48
ATM Q13315 1/20 0.48
LMNA P02545 1/20 0.42
GAA P10253 1/20 0.42
HSD17B10 Q99714 1/20 0.41
RARA P10276 1/20 0.40
RARB P10826 1/20 0.40
RARG P13631 1/20 0.40
MAPT P10636 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
ESR1 P03372 4/20 0.39
ESR2 Q92731 4/20 0.39
FFAR1 O14842 1/20 0.39
HSD17B1 P14061 2/20 0.38
HSD17B2 P37059 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17433306 0.93 ELANE (0.51) ELANEKMT2AATMLMNAGAA
SCHEMBL10014244 0.93 ELANE (0.47) ELANEKMT2AATMMAPTTDP1
SCHEMBL11961803 0.93 ELANE (0.51) ELANEKMT2AATMLMNAGAA
SCHEMBL22078754 0.89 HSD17B1 (0.51) ELANEKMT2AATMFFAR1HSD17B1
SCHEMBL17754326 0.89 ESR1 (0.53) ELANEKMT2AATMESR1ESR2
SCHEMBL803168 0.88 ELANE (0.62) ELANEKMT2AATMLMNAGAA
SCHEMBL12872192 0.88 ELANE (0.62) ELANEKMT2AATMLMNAGAA
SCHEMBL17433304 0.88 ELANE (0.62) ELANEKMT2AATMLMNAGAA
SCHEMBL11961798 0.86 ELANE (0.46) ELANEKMT2AATMLMNAGAA
SCHEMBL17081094 0.86 ELANE (0.57) ELANEKMT2AATMLMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020116555-A1 LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT DIC株式会社 2020-06-11 WO disclosed